(Q40910611)

24 September 2017

1 reference

title

The increasing efficacy of breast cancer treatment (English)

1 reference

24 September 2017

Gordon A

1

1 reference

24 September 2017

publication date

1 January 1997

1 reference

24 September 2017

1 reference

24 September 2017

volume

9

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

338-342

1 reference

Prognostic factors and therapeutic decisions in axillary node-negative breast cancer

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Psychosocial correlates of survival in advanced malignant disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Occasional notes. The management of early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Surgery for breast cancer. Less may be as good as more

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Radiotherapy and the management of the axilla in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Breast cancer therapy: exercising all our options

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Current status of paclitaxel in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

The clinical use of colony stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Molecular themes in oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Molecular approaches to cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Inhibition of Breast Cancer Growth by Suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Immune modulation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Gene therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

Evidence for a novel gene associated with low tumor metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980069-X

7 January 2021

10.1016/S0936-6555(05)80069-X

Identifiers

DOI

1 reference

24 September 2017

1 reference